Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pickering

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
The Journal of Heart Valve Disease|November 1, 1995
Use of larger sized aortic homograft conduits in right ventricular outflow tract reconstructionR K Tam, M J Tolan, V Y Zamvar, et al.
BMC Cancer|July 26, 2018
Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinomaJie Ma, Yong Fu, Yao-Yao Tu, et al.
Cancer|July 2, 2011
Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational statusVlad C Sandulache, Heath D Skinner, Thomas J Ow, et al.
Seminars in Radiation Oncology|August 30, 2021
Biology of the Radio- and Chemo-Responsiveness in HPV MalignanciesMichael T Spiotto, Cullen M Taniguchi, Ann H Klopp, et al.
Cancer|August 16, 2020
Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinomaFrederico O Gleber-Netto, David Neskey, Ana Flávia de Mattos Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancerDaisuke Sano, Tong-Xin Xie, Thomas J Ow, et al.
Cancer Letters|May 29, 2018
Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutantsNene N Kalu, Tuhina Mazumdar, Shaohua Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
High-Risk <i>TP53</i> Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell CarcinomaVlad C Sandulache, Chieko Michikawa, Pranav Kataria, et al.
Translational Oncology|February 27, 2018
Risk Stratification of Oral Potentially Malignant Disorders in Fanconi Anemia Patients Using Autofluorescence Imaging and Cytology-On-A Chip AssayTimothy J Abram, Curtis R Pickering, Alexander K Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2022
Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven CancersSoma Ghosh, Tuhina Mazumdar, Wei Xu, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
The Journal of Heart Valve Disease|November 1, 1995
Use of larger sized aortic homograft conduits in right ventricular outflow tract reconstructionR K Tam, M J Tolan, V Y Zamvar, et al.
BMC Cancer|July 26, 2018
Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinomaJie Ma, Yong Fu, Yao-Yao Tu, et al.
Cancer|July 2, 2011
Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational statusVlad C Sandulache, Heath D Skinner, Thomas J Ow, et al.
Seminars in Radiation Oncology|August 30, 2021
Biology of the Radio- and Chemo-Responsiveness in HPV MalignanciesMichael T Spiotto, Cullen M Taniguchi, Ann H Klopp, et al.
Cancer|August 16, 2020
Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinomaFrederico O Gleber-Netto, David Neskey, Ana Flávia de Mattos Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancerDaisuke Sano, Tong-Xin Xie, Thomas J Ow, et al.
Cancer Letters|May 29, 2018
Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutantsNene N Kalu, Tuhina Mazumdar, Shaohua Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
High-Risk <i>TP53</i> Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell CarcinomaVlad C Sandulache, Chieko Michikawa, Pranav Kataria, et al.
Translational Oncology|February 27, 2018
Risk Stratification of Oral Potentially Malignant Disorders in Fanconi Anemia Patients Using Autofluorescence Imaging and Cytology-On-A Chip AssayTimothy J Abram, Curtis R Pickering, Alexander K Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2022
Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven CancersSoma Ghosh, Tuhina Mazumdar, Wei Xu, et al.
Pageof 17